These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6447123)

  • 1. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):530-7. PubMed ID: 6447122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells.
    Devens B; Naor D
    J Immunol; 1979 Apr; 122(4):1397-401. PubMed ID: 312839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to weakly immunogenic virally induced tumors. II. Suppressive effects of the in vivo carried tumor YAC.
    Devens B; Galili N; Deutsch O; Naor D; Klein E
    Eur J Immunol; 1978 Aug; 8(8):573-8. PubMed ID: 699954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune responses to weakly immunogenic virally induced tumors. VI. Comparison of the immune response of the hybrid to the immune responses of the parents reveals "hybrid responsiveness" effect.
    Devens B; Naor D
    J Immunol; 1980 Sep; 125(3):988-94. PubMed ID: 6447725
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to weakly immunogenic virally induced tumors. I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross-reactive tumor.
    Galili N; Devens B; Naor D; Becker S; Klein E
    Eur J Immunol; 1978 Jan; 8(1):17-22. PubMed ID: 639838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell-mediated immunity to oncornavirus-induced tumors. IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells.
    Leclerc JC; Plater C; Connan F; Debré P
    Eur J Immunol; 1981 Jan; 11(1):45-7. PubMed ID: 6452279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C; Debré P; Leclerc JC
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural suppressor cell inhibiting T killer responses against retroviruses: a model for self tolerance.
    Tilkin AF; Bègue B; Gomard E; Levy JP
    J Immunol; 1985 Apr; 134(4):2779-82. PubMed ID: 3156190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
    Tilkin AF; Gomard E; Begue B; Levy JP
    J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor.
    Kobrin BJ; Naor D; Klein BY
    J Immunol; 1981 May; 126(5):1874-82. PubMed ID: 6260859
    [No Abstract]   [Full Text] [Related]  

  • 17. Accessory cells in the in vitro generation of type C viruses specific T killer lymphocytes. I. Role of macrophages in primary anti-FMR reaction.
    Gomard E; Wybier-Franqui J; Levy JP
    J Immunol; 1981 Mar; 126(3):891-6. PubMed ID: 6257785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
    Holden HT; Kirchner H; Herberman RB
    J Immunol; 1975 Aug; 115(2):327-31. PubMed ID: 168259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
    Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
    Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.